Danica Brister

Dr. Danica Brister

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
DBDanica Brister
Danica Brister
HOHafsa Omer
Hafsa Omer
CWChristiane Whetstone
Christiane Whetstone
MRMaral Ranjbar
Maral Ranjbar
GGGail Gauvreau
Gail Gauvreau
Disruption of the airway epithelium triggers a defensive immune response that begins with the production and release of alarmin cytokines. These epithelial-derived alarmin cytokines, including thymic stromal lymphopoietin (TSLP), are produced in response to aeroallergens, viruses, and toxic inhalants. An alarmin response disproportionate to the inhaled trigger can exacerbate airway diseases such as asthma. Allergens inhaled into previously sensitized airways are known to drive a T2 inflammatory response through the polarization of T cells by dendritic cells mediated by TSLP. Harmful compounds found within air pollution, microbes, and viruses are also triggers causing airway epithelial cell release of TSLP in asthmatic airways. The release of TSLP leads to the development of inflammation which, when unchecked, can result in asthma exacerbations. Genetic and inheritable factors can contribute to the variable expression of TSLP and the risk and severity of asthma. This paper will review the various triggers and consequences of TSLP release in asthmatic airways.

18 February 2023 in Lung
Verified
Journal Article
Closed access
PDF file
EKElena Kum
Elena Kum
DBDanica Brister
Danica Brister
NDNermin Diab
Nermin Diab
MWMustafaa Wahab
Mustafaa Wahab
TATed Abraham
Ted Abraham
ISImran Satia
Imran Satia

3 April 2023 in Expert Opinion on Emerging Drugs
Verified
Journal Article
Closed access
DBDanica Brister
Danica Brister
MWMustafaa Wahab
Mustafaa Wahab
MRMoaaz Rashad
Moaaz Rashad
NDNermin Diab
Nermin Diab
MKMartin Kolb
Martin Kolb
ISImran Satia
Imran Satia
Chronic cough is a debilitating condition that is among the most common reasons for seeking medical attention yet remains challenging to manage. Identifying an underlying respiratory, nasal or uppe...

Verified
Journal Article
Open access
PDF file
MRMaral Ranjbar
Maral Ranjbar
RCRuth Cusack
Ruth Cusack
CWChristiane Whetstone
Christiane Whetstone
DBDanica Brister
Danica Brister
JWJennifer Wattie
Jennifer Wattie
GGGail Gauvreau
Gail Gauvreau
Background: The immune response dynamics in COVID-19 patients remain a subject of intense investigation due to their implications for disease severity and treatment outcomes. We examined changes in leukocyte levels, eosinophil activity, and cytokine profiles in patients hospitalized with COVID-19. Methods: Serum samples were collected within the first 10 days of hospitalization/confirmed infection and analyzed for eosinophil granule proteins (EGP) and cytokines. Information from medical records including comorbidities, clinical symptoms, medications, and complete blood counts were collected at the time of admission, during hospitalization and at follow up approximately 3 months later. Results: Serum levels of eotaxin, type 1 and type 2 cytokines, and alarmin cytokines were elevated in COVID-19 patients, highlighting the heightened immune response (p < 0.05). However, COVID-19 patients exhibited lower levels of eosinophils and eosinophil degranulation products compared to hospitalized controls (p < 0.05). Leukocyte counts increased consistently from admission to follow-up, indicative of recovery. Conclusion: Attenuated eosinophil activity alongside elevated chemokine and cytokine levels during active infection, highlights the complex interplay of immune mediators in the pathogenesis COVID-19 and underscores the need for further investigation into immune biomarkers and treatment strategies.